Your browser doesn't support javascript.
loading
Analysis of the Legislative Evolution and Causes of Biologics Data Protection System in the United States / 中国药房
China Pharmacy ; (12): 1302-1306, 2017.
Article in Chinese | WPRIM | ID: wpr-515017
ABSTRACT

OBJECTIVE:

To study the legislative evolution and causes of biologics data protection system in the United States, and provide reference for designing biologics data protection system in China.

METHODS:

Started from analyzing the features of biologics data protection in the United States,through analyzing the legislative struggle of biologics data protection in the United States,the caused and its enlightenment to China were explored. RESULTS &

CONCLUSIONS:

After legislative discussion evolu-tion and struggle,the United States enacted the Biologics Price Competition and Innovation Act in 2010,established the world's firststrong protectionstandard of biologics data protection system,and determined the 12-year data protection period. The legisla-tive basis was to stimulate the strategic needs of innovation,the direct cause was that a biological analogue simplified application was established in the United States,and the key factors included biologics technical attributes and patent protection features. Cur-rently,biologics data protection system is not suitable for China,and China should implement the system from nothing,from weak to strong when the national condition matches or strategic choice needs. Meanwhile,a mature registration approval system is the ba-sis of establishing data protection system.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Etiology study Language: Chinese Journal: China Pharmacy Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Etiology study Language: Chinese Journal: China Pharmacy Year: 2017 Type: Article